Stem cell banking market projected to reach $31.58 billion by 2035

The global stem cell banking market is expected to grow significantly, reaching an estimated value of $31.58 billion by 2035. Valued at $10 billion in 2025, the sector is projected to expand at a compound annual growth rate (CAGR) of 12.22% between 2026 and 2035.

Growth is driven by increasing interest in regenerative medicine, advancements in cell-based therapies, and improvements in cryopreservation technologies. Key sources for banking include umbilical cord blood and umbilical cord tissue, which are collected and processed for potential future medical uses such as transplants and tissue repair.

Consumer demand is largely supported by neonatal stem cell preservation, where families opt for private banking services to secure biological materials at birth. While technological advancements like digital inventory platforms and enhanced monitoring systems are improving sample traceability and integrity, long-term market success remains dependent on affordability, clinical evidence, and the availability of approved treatments.